OncoCyte Corp (OCX) — Cash Flow Quality Index
Latest as of March 2023:
-3.19x
OncoCyte Corp (OCX) has a Cash Flow Quality Index of -3.19x as of March 2023. Operating cash flow of $-9.67 Million is below net income of $3.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore OncoCyte Corp (OCX) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-3.19x
Operating CF / Net Income
Operating Cash Flow
$-9.67 Million
USD
Net Income
$3.03 Million
USD
Data as of
Mar 2023
Most recent filing
Annual Cash Flow Quality Index for OncoCyte Corp (None–None)
Year-by-year earnings quality comparison for OncoCyte Corp. For live market cap and the full company financial profile, see OncoCyte Corp (OCX) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.